What's the deal with Zenith?

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Texbraska

Rank: Mail Room [?]

Points: 247 [?]

Votes: 9 Score: 4.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

What's the deal with Zenith?

posted on Jun 21, 2023 04:54PM

Thanks in advance for any hints about this.

After watching the RVX AGM I'm scratching my head about this company. I know the stock isn't exactly easy to access, but why is the value so ridiculously low? It looks like the drugs are actually working, and there are several pharma's paying Zenith's research costs. What am I missing? Seems like an excellent risk if the stock can be found, no?

3 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply